Drug class
Peroxisome Proliferator-activated Receptor Agonist
Mechanism of action
Peroxisome Proliferator-activated Receptor Agonists [MoA]
General use cases
- Liver Cirrhosis, Biliary
- primary biliary cholangitis (PBC) in combination with ursodeoxycholic acid (UDCA) in adults who have had an inadequate response to UDCA, or as monotherapy in patients unable to tolerate UDCA
- primary biliary cholangitis (PBC) in combination with ursodeoxycholic acid (UDCA) in adults who have an inadequate response to UDCA, or as monotherapy in patients unable to tolerate UDCA
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
